Even a defense system can become dangerous if left unchecked.
Within the microscopic interior of every living cell, a hidden layer of self-defense has long operated beyond scientific understanding. Japanese researchers at Juntendo and Hokkaido Universities have now illuminated how cells can activate their master antioxidant switch — NRF2 — without first detecting oxidative damage, through a mechanism involving protein droplets called p62 bodies that physically trap the suppressor protein KEAP1. This discovery, published in The EMBO Journal, reveals that cellular resilience is more architecturally complex than previously known, and that the same protective machinery, when dysregulated, may underlie some of humanity's most persistent diseases.
- A decades-old gap in cell biology has been closed: scientists never fully understood how NRF2 could activate without oxidative stress — now they do, and the answer lies in self-assembling molecular droplets.
- The p62 body mechanism operates like a cellular ambush — ULK1 kinase enters the droplet, chemically tags p62, and the newly phosphorylated protein locks KEAP1 in place, freeing NRF2 to mount a defense response.
- Mouse models engineered with hyperactive p62 phosphorylation suffered alarming consequences — thickened stomach and esophageal linings, inability to eat, and stunted growth — a warning that even protective systems carry the seeds of harm.
- Abnormal p62 accumulation is already documented in liver disease, Parkinson's, Alzheimer's, and multiple cancers, making this newly mapped pathway a potential fault line running beneath several major disease categories.
- Researchers now aim to learn how to modulate p62 phosphorylation and autophagy with precision, hoping to open therapeutic pathways for conditions where this cellular defense network has either gone silent or spiraled out of control.
Inside every cell, a quiet war is fought against molecular damage. Reactive oxygen species — toxic byproducts of normal metabolism — threaten proteins, fats, and DNA. The cell's most celebrated defense is a pathway governed by NRF2, a master switch that activates antioxidant genes. The long-accepted model held that oxidative stress triggers the sensor protein KEAP1, which then releases NRF2 to act. Yet NRF2 was known to activate even in the absence of oxidative stress, and the mechanism behind this remained unexplained — until now.
A team led by Professor Masaaki Komatsu and Associate Professor Yoshinobu Ichimura, working across Juntendo University School of Medicine and Hokkaido University, has identified the missing mechanism. When cells accumulate damaged proteins, a protein called p62 binds to them and forms tiny liquid droplets — p62 bodies — through a process called liquid-liquid phase separation. Using atomic force microscopy and fluorescence imaging, the researchers watched what unfolds inside these droplets: a kinase called ULK1 enters, phosphorylates p62, and the altered protein becomes a molecular trap for KEAP1. With KEAP1 held captive, NRF2 is liberated to activate cellular defenses. Autophagy eventually dismantles the p62 bodies, switching the pathway off.
The discovery carries both promise and caution. In mice engineered for hyperactive p62 phosphorylation, the pathway's excess caused hyperkeratosis of the stomach and esophageal lining, leaving the animals unable to eat and stunted by malnutrition — a vivid demonstration that defense systems, unregulated, become threats in themselves.
The broader significance is considerable. Abnormal p62 accumulation has been observed in liver disease, neurodegeneration including Parkinson's and Alzheimer's, and various cancers — conditions where the p62-NRF2-autophagy network appears either dormant or dangerously overactive. The researchers believe their findings, published in The EMBO Journal, lay the groundwork for understanding how this pathway fails and how it might be therapeutically corrected, potentially offering new approaches to diseases that have long resisted intervention.
Inside every cell, a constant battle rages against molecular damage. When reactive oxygen species accumulate—the toxic byproducts of normal metabolism—they corrode proteins, fats, and DNA. Cells have evolved multiple defense systems to fight back. The most famous is a pathway controlled by a master switch called NRF2, a protein that flips on genes encoding antioxidant defenses. For decades, scientists understood how this worked: oxidative stress triggers a sensor protein called KEAP1, which then releases NRF2 to do its job. But NRF2 can also activate without any oxidative stress at all, and until recently, how that happened remained a mystery.
A team of Japanese researchers has now solved that puzzle. Working across Juntendo University School of Medicine and Hokkaido University, they discovered that cells can trigger NRF2 through a completely different mechanism—one that doesn't depend on detecting free radicals at all. The key player is a protein called p62, which forms tiny droplets inside cells when it binds to damaged proteins. These droplets, called p62 bodies, act like molecular containers created through a process called liquid-liquid phase separation. Think of them as stress-response depots that assemble on demand.
The researchers, led by Professor Masaaki Komatsu and Associate Professor Yoshinobu Ichimura, used cutting-edge tools including atomic force microscopy and fluorescence imaging to watch what happens inside these p62 bodies. They found that a protein kinase called ULK1 travels into the bodies and phosphorylates p62—essentially adding a chemical tag that changes its shape and behavior. Once phosphorylated, p62 becomes a trap. It grabs hold of KEAP1, the same protein that normally suppresses NRF2, and holds it prisoner inside the p62 body. With KEAP1 sequestered and unable to do its job, NRF2 breaks free and activates the cell's antioxidant defenses. The p62 bodies themselves are eventually broken down by autophagy, a cellular recycling process that shuts down the pathway.
This discovery matters because it reveals a second, independent route to cellular protection—one that doesn't require the cell to sense oxidative damage first. The researchers tested this in mice engineered to have hyperactive p62 phosphorylation. The results were striking and sobering. Excessive activation of this pathway caused hyperkeratosis, a thickening of the outer layer of the stomach and esophageal lining. The mice couldn't eat properly and suffered stunted growth from malnutrition. The finding underscores a crucial principle: even a defense system can become dangerous if left unchecked.
The implications ripple outward. Abnormal accumulation of p62 bodies has been documented in patients with liver disease, neurodegenerative conditions like Parkinson's and Alzheimer's, and various cancers. In these diseases, the p62-NRF2-autophagy network appears to malfunction, either failing to activate when needed or becoming stuck in overdrive. Komatsu and his colleagues believe their work provides the foundation for understanding how these pathways go wrong and, crucially, how to fix them. Their findings, published in The EMBO Journal, represent the first rigorous validation that this redox-independent activation pathway has real biological significance. The next frontier is learning how to modulate phosphorylation and autophagy of p62 bodies—potentially opening new therapeutic doors for diseases where this system has broken down.
Citações Notáveis
Whether redox-dependent or independent, NRF2 activation is an important biological defense system. Understanding its regulatory mechanisms is crucial as its persistent activation leads to inordinate defense responses.— Professor Masaaki Komatsu, Juntendo University School of Medicine
A Conversa do Hearth Outra perspectiva sobre a história
So cells have two completely separate ways to activate NRF2? That seems redundant.
Not really. The oxidative pathway is fast and direct—it senses danger immediately. But the p62 pathway responds to a different kind of problem: when proteins are already damaged and piling up. It's like having both a smoke detector and a heat sensor.
And the p62 bodies are these droplets that form spontaneously?
Yes, through phase separation. When p62 binds to damaged proteins, it undergoes a phase transition—like oil separating from water. The bodies concentrate p62 and other proteins in one place, making the chemistry much more efficient.
What happens to KEAP1 when it gets trapped inside?
It's physically sequestered. Phosphorylated p62 binds so tightly that KEAP1 can't escape or do its normal job of suppressing NRF2. It's held in place until autophagy degrades the whole body.
The mouse experiment showed this can go wrong. How common is that in human disease?
We don't know yet. But p62 accumulation is documented in liver disease, neurodegeneration, and cancer. Whether it's cause or consequence is still an open question—that's where the real therapeutic work begins.